Amplifon S.p.A Other Non-Current Liabilities 2019-2024 | AMFPF

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Amplifon S.p.A other non-current liabilities for 2024 were $0.252B, a 5.99% increase from 2023.
Amplifon S.p.A other non-current liabilities for 2023 were $0.238B, a 10.44% increase from 2022.
Amplifon S.p.A other non-current liabilities for 2022 were $0.215B, a 21.8% decline from 2021.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Amplifon S.p.A other non-current liabilities for 2024 were $0.252B, a 5.99% increase from 2023.
Amplifon S.p.A other non-current liabilities for 2023 were $0.238B, a 10.44% increase from 2022.
Amplifon S.p.A other non-current liabilities for 2022 were $0.215B, a 21.8% decline from 2021.

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$141.5B
CVS Health (CVS)	$81.4B
Elevance Health (ELV)	$76.8B
Cencora (COR)	$57.6B
DiDi Global (DIDIY)	$25.2B
Natera (NTRA)	$21.6B
Labcorp Holdings (LH)	$20.9B
BioMerieux (BMXMF)	$16.9B
EUROFINS SCIENT (ERFSF)	$13.3B
CochLear (CHEOY)	$13B
Solventum (SOLV)	$12.8B
ICON (ICLR)	$12.1B
Revvity (RVTY)	$11.6B
Viatris (VTRS)	$10.7B
Medpace Holdings (MEDP)	$9.2B
Avantor (AVTR)	$9B
Sonic Healthcare (SKHHY)	$8.8B
HealthEquity (HQY)	$8.4B
Charles River Laboratories (CRL)	$7.8B
Caris Life Sciences,�Inc (CAI)	$7.1B
Bausch + Lomb (BLCO)	$4.8B
BrightSpring Health Services (BTSG)	$3.6B
Sotera Health (SHC)	$3.3B
Surgery Partners (SGRY)	$2.9B
Alignment Healthcare (ALHC)	$2.7B
Concentras Parent (CON)	$2.6B
Organon (OGN)	$2.6B
GeneDx Holdings (WGS)	$2.4B
Ardent Health (ARDT)	$2.1B
Progyny (PGNY)	$2B